Trials / Completed
CompletedNCT04309916
Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance
A Multicenter, Double-blind, Randomized, Active-controlled Phase 4 (Pilot) Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study aims to compare the nighttime heartburn and sleep disturbance improvement effect of Tegoprazan 50mg and Eomeprazole 40mg in patients with ERD patients.
Detailed description
This is a multi-center, double-blind, randomized, active-controlled phase 4 (pilot) study. Subjects will be randomly assigned to one of the two treatment groups (tegoprazan 50mg, esomeprazole 40mg)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegoprazan | Tegoprazan 50mg tablet |
| DRUG | Esomeprazole | Esomeprazole 40mg tablet |
Timeline
- Start date
- 2020-05-22
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
- First posted
- 2020-03-17
- Last updated
- 2022-02-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04309916. Inclusion in this directory is not an endorsement.